Skip to main content

Table 1 Clinical and laboratory parameters of patients with Clostridium difficile infection and correlation with fecal Calprotectin levels

From: Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection

Parameter

Mean

(percent/range)

fc levels (μg/g),

mean (range)

P -value for correlation with fc levels

Antibiotic-reduced susceptibility

   

 Metronidazole

3 (10.3 %)

Reduced susceptibility to Metronidazole: 177.7 (46–287)

0.5474

Metronidazole susceptible 349 (21–932)

 Vancomycin

5 (17.2 %)

Reduced susceptibility to Vancomycin 336.8 (113–932)

0.7316

Vancomycin susceptible 330.3 (21–912)

Gender

   

 Male

15 (51.7 %)

340.8 (48–932)

 

 Female

14 (48.3 %)

321.4 (21–911)

0.7622

Age (years)

64.5 (17–95)

 

0.2764

Functional status

   

 Independent

14 (48.3 %)

316.8 (21–932)

 

 Debilitated

15 (51.7 %)

45.1 (46–911)

0.6815

CDI acquisition

   

 Community

10 (34.5 %)

273.6 (21–911)

 

 Nursing home

3 (10.3 %)

234.7 (21–411)

 

 Hospital

16 (55.2 %)

385.8 (46–932)

0.5678

Body temperature (°C)

37.0 (36–39.4)

 

0.8772

Peripheral white blood cell count (/μl)

13,363 (3070–43,210)

 

0.0007

Creatinine(g/dL)

1.3 (0.2–6.7)

 

0.2

Disease recurrence in 30 days

10 (34.5 %)

Disease recurrence 284.7 (46–800)

0.6662

No recurrence 356.1 (21–932)

30 day mortality

   

 Yes

2 (6.9 %)

579.5 (248–911)

 

 No

27 (93.1 %)

313.3 (21–932)

0.2550

Clostridium severity score index

2.17 (1–6)

 

0.0633